These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 22335056

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Lipid disorders.
    Kole LA.
    JAAPA; 2009 Nov; 22(11):54-5. PubMed ID: 19999177
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Setting a new standard in achieving superior efficacy: ezetimibe + simvastatin.
    Farnier M.
    Fundam Clin Pharmacol; 2007 Nov; 21 Suppl 2():27-8. PubMed ID: 18001317
    [Abstract] [Full Text] [Related]

  • 6. Fluvastatin/fenofibrate vs. simvastatin/ezetimibe in patients with metabolic syndrome: different effects on LDL-profiles.
    Westerink J, Visseren FL.
    Eur J Clin Invest; 2010 Jan; 40(1):87. PubMed ID: 19912317
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Efficacy of simvastatin and ezetimibe in treating hypercholesterolemia.
    Davidson MH.
    J Am Coll Cardiol; 2003 Jul 16; 42(2):398-9; author reply 399. PubMed ID: 12875794
    [No Abstract] [Full Text] [Related]

  • 10. Efficacy and safety of ezetimibe and low-dose simvastatin as primary treatment for dyslipidemia in peritoneal dialysis patients.
    Suzuki H, Inoue T, Watanabe Y, Kikuta T, Sato T, Tsuda M.
    Adv Perit Dial; 2010 Jul 16; 26():53-7. PubMed ID: 21348380
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Ezetimibe combines with simvastatin to tackle cholesterol. New drugs attack "bad" cholesterol in the liver and intestine.
    Heart Advis; 2007 Jul 16; 10(7):7. PubMed ID: 17695657
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Influence of simvastatin, fenofibrate and/or ezetimibe on correlation of low-density lipoprotein and nonhigh-density lipoprotein cholesterol with apolipoprotein B in mixed dyslipidemic patients.
    Farnier M, Taggart W, Dong Q, Lin J, Shah A, Brudi P.
    J Clin Lipidol; 2011 Jul 16; 5(3):179-187. PubMed ID: 21600523
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Ezetimibe is effective in the treatment of persistent hyperlipidemia of renal allograft recipients.
    Savvidaki E, Koukoulaki M, Benou A, Roumeliotou M, Fourtounas C, Kalliakmani P, Papachristou E, Vlachojannis JG, Goumenos D.
    Clin Nephrol; 2011 Feb 16; 75(2):107-12. PubMed ID: 21255539
    [Abstract] [Full Text] [Related]

  • 19. The antilipidemic effects of ezetimibe in patients with diabetes.
    Stroup JS, Kane MP, Busch RS.
    Diabetes Care; 2003 Oct 16; 26(10):2958-9. PubMed ID: 14514611
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.